Faron Pharmaceuticals Oy Share Forecast, Price & News

Wall Street analysts have given Faron Pharmaceuticals Oy a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Faron Pharmaceuticals Oy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Faron Pharmaceuticals Oy's stock was trading at GBX 297.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, FARN shares have increased by 21.0% and is now trading at GBX 360.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Faron Pharmaceuticals Oy include Achilles Therapeutics plc American Depositary Shares (ACHL), Biotest Aktiengesellschaft (BIO), Aptose Biosciences (APS), Burcon NutraScience (BU), Sigilon Therapeutics (SGTX), Ergomed (ERGO), Inventiva (IVA), 22nd Century Group (XXII), Silence Therapeutics (SLN), Gemini Therapeutics (GMTX), Landos Biopharma (LABP), Terns Pharmaceuticals (TERN), BELLUS Health (BLU), Pfenex (PFNX) and Sensei Biotherapeutics (SNSE).
View all of FARN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Faron Pharmaceuticals Oy investors own include Horizon Discovery Group plc (HZD.L) (HZD), (CELG), Acura Pharmaceuticals (ACUR), Carnival Co. & (CCL), Alphabet (GOOG), Hurricane Energy (HUR), International Consolidated Airlines Group (IAG), Northwest Pipe (NWPX), Petropavlovsk (POG) and 760792 (TQNT).

Faron Pharmaceuticals Oy trades on the London Stock Exchange (LON) under the ticker symbol "FARN."

Shares of FARN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of FARN stock can currently be purchased for approximately GBX 360.

Faron Pharmaceuticals Oy has a market capitalization of £181.50 million and generates £2.12 million in revenue each year.

Faron Pharmaceuticals Oy employs 24 workers across the globe.

The official website for Faron Pharmaceuticals Oy is www.faron.com.

Faron Pharmaceuticals Oy is headquartered at Intelligate, Joukahaisenkatu 6, TURKU, 20520, Finland.

Faron Pharmaceuticals Oy's mailing address is Intelligate, Joukahaisenkatu 6, TURKU, 20520, Finland. The company can be reached via phone at +358-2-4695151.